HOME ZACKS RESEARCH FUNDS PORTFOLIO BROKER RESEARCH MARKETS SCREENING EDUCATION SERVICES
Zacks Rank    Equity Research    Premium Home    My Account    Help    

Zacks Education
Visit Zacks'
Education section for investing guides and other free resources to make you a better investor.
Quote:
Login Free Membership
Search:

 
Analyst Blog  

Plexus Cut to Neutral

September 01, 2009 | Comments: 0
Recommended this article (0)
PLXS | JNPR | FLEX | JBL | BHE | SANMD
Print    Share

Plexus Corp.
(PLXS - Analyst Report) is a leading provider of electronic manufacturing services (EMS) to original equipment manufacturers (OEMs) and serves customers of mid-to-low volume, higher margin and high growth segments of the EMS market. We recently downgraded the stock from Outperform to Neutral due to some inherent risks.

The company’s third-quarter results were in line with management’s guidance, with revenue exceeding the Zacks Consensus estimate. However, performance of all its sectors declined sequentially. The company’s fourth-quarter guidance was decent.

We believe that Plexus is among the best positioned in the industry. With a strong pipeline, new customer wins and increased cost-cutting measures, the company is poised for growth beyond 2009.

However, the contract manufacturing industry is highly competitive and margins have been low throughout the industry. Plexus is small player compared to peers, such as Flextronics International Ltd. (FLEX - Snapshot Report), Jabil Circuit (JBL - Analyst Report), Benchmark Electronics (BHE - Analyst Report) and Sanmina-SCI (SANMD).

Moreover, the company is currently dependent on few large customers for a large part of its revenue. Juniper Networks (JNPR) accounts for 23% of its total revenue. Given the competitive nature of the industry, the loss of any one of its key customers or individual projects with these customers would severely impact Plexus’ results.

Plexus is witnessing a relatively low level of demand volatility, perhaps indicating that the end markets are finally stabilizing. But we advise investors to remain cautious until we see some more tangible benefit from the stabilization in its legacy customer programs and stronger end-market recovery. Our six-month price target on Plexus is $26.


Email

Print

Share

RSS

Rate Pos

Rate Neg

Comment
Read/Post Comments (0) | Recommended this article (0)
 Posting Comment...
There was a problem posting this this comment. Please try back later.
[CLICK TO CLOSE X]
Comments (Limit 1000 Characters - Used: 0)
Display Name: Email Address:  
 Loading Comments...
Be the first to comment on this article!
Best Stocks. Best Insight. Join Now...it's FREE!
Over 550,000 investors look forward to the timely insights in our email newsletter; Zacks Profit from the Pros. In each daily issue you will find:
  • Free  Four Zacks #1 Rank "Strong Buy" Stocks
  • Free  Timely Market Commentary
  • Free  Wealth Management Tips
  • Free  Profitable Strategy Screens
  • Free  Bull and Bear Stocks of the Day
Zacks FREE Registration

More Zacks Resources

Market Summary Nov 25, 2009 17:22 pm ET
DJIA 10464.4  30.69 0.29%
NASD 2176.05  6.87 0.32%
S&P 500 1110.63  4.98 0.45%
Sponsored Links